	Paediatric palliative care in advanced cystic fibrosis: from prognosis-based to needs-based care across the disease trajectory. Paediatr Respir Rev Rodrigues-Tiago B, Rolão-Carvalho C, Reis-Pina P. PMID: 42918687 [PubMed - as supplied by publisher]
	Hyperpolarized Xenon 129 MRI to Evaluate Regional Gas-Exchange Abnormalities in Cystic Fibrosis Lung Disease. Radiol Cardiothorac Imaging Soderlund SA, Masokano BI, Willmering MM, Bdaiwi AS, Hussain R, Kramer EL, Walkup LL, Cleveland ZI. PMID: 42911106 [PubMed - indexed for MEDLINE]
	Adverse events during cystic fibrosis transmembrane conductance regulator modulator therapy in children with cystic fibrosis: an observational study. Pharmacol Rep Osi, Naro, Sapiejka E, Famulska P, T, Steinert-Dymecki A, Koz, Jó, Nowakowska-Lewicka J, Bienert A, Wojsyk-Banaszak I. PMID: 42909792 [PubMed - as supplied by publisher]
	Longitudinal changes in bone mineral density among adults with cystic fibrosis: a systematic review and meta-analysis. Osteoporos Int Selvarajah A, Dittrich A, Mohandas V, Sykes J, Jad R, Strug LJ, Booth G, Batt J, Stephenson AL. PMID: 42909486 [PubMed - as supplied by publisher]
	Changes in Gastrointestinal Symptoms Among Children With Cystic Fibrosis During 12â€‰Months of Elexacaftor/Tezacaftor/Ivacaftor Therapy: A Swedish Multicentre Study. Acta Paediatr Svedberg M, Nilsson EK, Ekman P, Imberg H. PMID: 42904852 [PubMed - as supplied by publisher]
	Natural products shape microbial ecology and disease in the cystic fibrosis airway. Nat Prod Rep Bhowmik N, Stubbendieck RM. PMID: 42902746 [PubMed - as supplied by publisher]
	Bacteriophage Therapy in Cystic Fibrosis: Emerging Strategies for Managing Chronic Pseudomonas aeruginosa Infections. Drug Des Devel Ther Puthenpurayil A, Gordon L, Fothergill JL. PMID: 42898652 [PubMed - indexed for MEDLINE]
	Non-eligibility for highly effective modulator therapy with elexacaftor/tezacaftor/ivacaftor in cystic fibrosis: What about Portugal? Pulmonology Fragoso E, Azevedo P, Pereira L, Barbosa T, Cardoso AL, Cruz CM, Amorim A, Azevedo I, Almeida L, Castanhinha S, Santos AS, Gamboa F, Reis Silva T, Freitas C, Teixeira V, Carreiro A, Gonçalves J. PMID: 42898061 [PubMed - indexed for MEDLINE]
	Distinct gastrointestinal symptom phenotypes in adults with cystic fibrosis are linked to complications and medication use: the GRAMPUS-CF study. J Cyst Fibros Holaman J, Sills D, Saumtally H, Johnson C, Recto A, Marsh R, Prayle A, Gathercole K, Monaghan T, Marciani L, Spiller R, Barr HL, Downey DG, van der Gast C, Peckham D, Stewart I, Smyth A. PMID: 42888123 [PubMed - as supplied by publisher]
	Nutritional Care in Cystic Fibrosis Across the Arab World: Regional Heterogeneity, Current Evidence, and Future Directions. Nutrients Shaikhkhalil AK, Abu-Hasan M, Sharpe S, Asfour F. PMID: 42884638 [PubMed - indexed for MEDLINE]
	CFTR Functional Rescue and Heterogeneous Clinical Outcomes Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis Carrying the W1282R Variant. Int J Mol Sci Kondratyeva E, Efremova A, Melyanovskaya Y, Zhekaite E, Sapelnikova M, Milovanov M, Shchagina O, Voronkova A, Sherman V, Krasovsky S, Kutsev S, Goldshtein D. PMID: 42884140 [PubMed - indexed for MEDLINE]
	Beyond Tuberculosis: Late Diagnosis of Cystic Fibrosis in an Adolescent with Bronchiectasis and Recurrent Pseudomonas aeruginosa Isolation: A Case Report. Diagnostics (Basel) Mihailov OM, Lu, , Mihailov R, Stav, . PMID: 42882257 [PubMed]
	Late-Diagnosed Cystic Fibrosis with Co-Occurring CFTR 3849+10kbC>T and 5T Variants: A Case Report. J Clin Med Popovici P, Mihai A, Butnariu LI, Popovici RM, Murgu AM, Tarc, Ioniuc IK, Rusu TE, Anton-P, Temneanu OR. PMID: 42882046 [PubMed]
	Model-informed dose reduction of elexacaftor/tezacaftor/ivacaftor therapy in adult people with cystic fibrosis: A simulation study. J Cyst Fibros Zwart TC, Baromeo SB, Bronsveld I, Heijerman HG, Wilms EB, van der Meer R. PMID: 42881074 [PubMed - as supplied by publisher]
	The impact of modulator therapy on the Pseudomonas aeruginosa cystic fibrosis lung transcriptome. Proc Natl Acad Sci U S A Letizia M, Whiteley LE, Diggle FL, Davis AN, Morgan SJ, Grogan B, Baugh J, McKone EF, Singh PK, Whiteley M. PMID: 42879475 [PubMed - indexed for MEDLINE]
	Assessment of Cystic Fibrosis Lung Disease Using Electrical Impedance Tomography. Pediatr Pulmonol Boas H, Bennett L, Faerber J, Donnelly EC, Gari M, Sailman GE, Pierdomenico A, Napolitano N, Dorgan D, Panitch HB, Ren CL. PMID: 42878537 [PubMed - indexed for MEDLINE]
	Fractional exhaled nitric oxide in non-cystic fibrosis bronchiectasis: an exploratory prospective observational study. Monaldi Arch Chest Dis Dilka E, Duraku E, Simaku A, Kapisyzi P. PMID: 42876314 [PubMed - as supplied by publisher]
	[Cystic Fibrosis in Latin America: Clinical Practices, Diagnosis, and Therapeutic Access: a Multicenter Cross-sectional Study]. Acta Gastroenterol Latinoam Higuera Carrillo M, Arregui MC, Arcucci MS, Reyes-Apodaca M, Navarro Díaz E, Sereno V, Oropeza Gianfelici G, Rodríguez Guerrero M, Jijón Andrade MC, Alomía M, Boldrini G, González Rozó N, Previte Nastasi P, Ortiz Paranza L. PMID: 42872225 [PubMed]
	Navigating School While Living With Cystic Fibrosis: Barriers and Support Strategies From the Patient and Family Perspective. Pediatr Pulmonol Heimbruch K, Strong S, Wackler M, Taylor M, Duan Q, Filigno SS, Hjelm M. PMID: 42870664 [PubMed - indexed for MEDLINE]
	How cystic fibrosis modulator therapy could transform Pseudomonas aeruginosa epidemiology. Microbiology (Reading) Gurney J, Letizia M, Azimi S, Diggle SP. PMID: 42867880 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 20257

Page 1 of 1013



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy